Nabriva Therapeutics plc reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dublin, Ireland
SEC filing record 1 source field available
Fiscal year end
31 December
Nabriva Therapeutics plc has filed 695 SEC EDGAR filings since 14 May 2015

SEC filing history

Showing 26-39 of 39 matching filings.

Per page
25
Current page
2
SC 13G/A File 005-89113

SC 13G/A

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

NABRIVA THERAPEUTICS AG - SCHEDULE 13GA (AMEND. #1)

Filing date
13 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

PHASE4 PARTNERS LTD SC 13GA 12-31-2016 (NABRIVA THERAPEUTICS AG)

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SEC SCHEDULE 13G

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

SC 13G/A

Filing date
08 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SC 13G

Filing date
29 Jul 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89113

SCHEDULE 13G/A FOR NABRIVA THERAPEUTICS AG BY THE WELLCOME TRUST LIMITED

Filing date
10 May 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SC 13G filing

Filing date
29 Apr 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SEC SCHEDULE 13G

Filing date
23 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SCHEDULE 13G

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

PHASE4 PARTNERS LTD SC 13G 9-23-2015 (NABRIVA THERAPEUTICS)

Filing date
12 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SC 13G

Filing date
05 Oct 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SCHEDULE 13G

Filing date
29 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-89113

SCHEDULE 13G

Filing date
25 Sep 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .